YWYimi Wang

Yimi Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yimi Wang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sarcopenia Is Associated With Increased Risk of Abnormal Sleep Duration in the Older People: A 10‐Year Cohort Study From China

    by Yimi Wang, Weixin Chen, Chun Wang, Lingzhi Li, Bingqing Bi, Shugang Li, Hao Wu

    Background: With the acceleration of the aging process, health issues of older people have gradually become one of the most important research topics. The older people experience significant reductions in muscle mass and physical performance. Cross‐sectional studies have found an association between the sarcopenia and sleep duration. Due to lack of evidence of longitude study, it is necessary to investigate the association between sarcopenia and sleep duration in the older people.Methods: This study utilized longitudinal data including 2061 older people from China Health and Retirement Longitudinal Study 2011–2020. Diagnosis was made based on the Asian Working Group for Sarcopenia criteria 2019. There were 246 participants with sarcopenia, 628 participants with possible sarcopenia and 1187 participants with nonsarcopenia. Kaplan–Meier curve, log‐rank test and Cox proportional risk model were used to explore the relationship between sarcopenia exposure and clinical outcome of abnormal sleep duration. Three models adjusting for different factors were built, and hazard ratios (HRs) were calculated. Restricted cubic spline analyses explored the exposure–response relationship between sarcopenia components and abnormal sleep duration incidence, while receiver operating characteristic curve was used to assess their predictive power.Results: The incidences of short or long, decreased sleep duration of the sarcopenia and possible sarcopenia groups in the overall population were significantly higher than those of the nonsarcopenia group (respectively, p < 0.001). Sarcopenia (HR = 1.240, 95% CI [confidence interval]: 1.023–1.417) was significantly associated with an increased risk of abnormal sleep duration by Cox model analysis with adjusting factors. Results of analyses stratified by sleep duration showed that sarcopenia (HR = 1.566, 95% CI: 1.192–2.057) and possible sarcopenia (HR = 1.286, 95% CI: 1.054–1.570) were positively associated with long sleep duration. Higher ASM (χ2 = 94.02, p < 0.001) and handgrip strength (χ2 = 94.55, p < 0.001), as well as lower five‐time chair stand test (χ2 = 81.33, p < 0.001) showed an exposure‐response relationship with sleep duration. The proportion of the condition of change in sleep duration from normal to < 6 h or > 8 h in the sarcopenia and possible sarcopenia groups was significantly different from the nonsarcopenia group (p < 0.05).Conclusions: Our results suggest that sarcopenia and possible sarcopenia are associated with abnormal sleep duration and the decrease of ASM and handgrip strength, and the increase of the five‐time chair stand test is positively related to abnormal sleep duration, which implies that delaying the development of sarcopenia could be a new pathway to improve sleep health in older people.


  • Open Access

    The Relationship Between Sleep Disorders and Combination of Diabetes and Sarcopenia in Adults Aged 45 Years or Older: 10-Year Nationwide Prospective Cohort Study

    by Shugang Li, Yimi Wang, Linzhi Li, Hao Wu

    Background: With changes in lifestyle, the issue of sleep disorders is becoming increasingly common. Diabetes and sarcopenia have been found to be independently associated with sleep disorders. However, fewer studies have explored the interaction between the combination of diabetes and sarcopenia at different stages and sleep disorders. Objective: This study aimed to explore the relationship between the combination of diabetes and sarcopenia and the incidence of sleep disorders in adults aged 45 years and older. Methods: Based on data from the CHARLS (China Health and Retirement Longitudinal Study), we selected participants with comprehensive diagnostic information on diabetes and sarcopenia from 2011 who had normal sleep duration at baseline and checked their follow-up information of sleep duration from 2013, 2015, 2018, and 2020. Diabetes was classified into diabetes (D), prediabetes (PD), and nondiabetes (ND), and sarcopenia was divided into sarcopenia (S), possible sarcopenia (PS), and nonsarcopenia (NS). The participants were divided into DS, DPS, DNS, PDS, PDPS, PDNS, NDS, NDPS, and NDNS groups. Kaplan-Meier survival curves, the log-rank test, Cox proportional hazards regression, and restricted cubic spline models were used for statistical analysis. Results: A total of 4936 participants were included in this study. The DS group had the highest incidence of sleep disorders: 49.32%, 28.57%, 36.36%, and 80.00% in 2013, 2015, 2018, and 2020 respectively. In the crude model, compared with the NDNS group, the risk of sleep disorders was increased in the DS group (hazard ratio [HR] 1.707, 95% CI 1.196‐2.437), PDS (HR 1.599, 95% CI 1.235‐2.071), NDS (HR 1.465, 95% CI 1.282‐1.674), and DPS group (HR 1.318, 95% CI 1.097‐1.583). The risk was increased but not statistically significant in the PDPS group (HR 1.160, 95% CI 0.987‐1.365). After adjusting for covariates, the risk of sleep disorders remained statistically significant in the DS group (HR 1.515, 95% CI 1.059‐2.167) and was significantly higher in the PDS (HR 1.423, 95% CI 1.096‐1.847) and NDS (HR 1.279, 95% CI 1.113‐1.468) groups than that in the NDNS group. The nonlinear associations between appendicular skeletal muscle mass, grip strength, 5-time chair test, fasting plasma glucose, and sleep disorders were observed and described. Conclusions: The combination of diabetes and sarcopenia significantly increases the risk of sleep disorders in adults aged 45 years and older. and the implementation of progression control of both diabetes and sarcopenia may be helpful to prevent sleep disorders in this population.